James B. Mangold

884 total citations
26 papers, 645 citations indexed

About

James B. Mangold is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, James B. Mangold has authored 26 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in James B. Mangold's work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (6 papers) and Carcinogens and Genotoxicity Assessment (3 papers). James B. Mangold is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (6 papers) and Carcinogens and Genotoxicity Assessment (3 papers). James B. Mangold collaborates with scholars based in United States, Switzerland and France. James B. Mangold's co-authors include Helen Gu, Heidi J. Einolf, Lolita C. Rodriguez, Handan He, Christiane Rordorf, Mahmoud M. Abdel‐Monem, Lai Wang, Volker Fischer, Yannick Batard and Hequn Yin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

James B. Mangold

26 papers receiving 621 citations

Peers

Countries citing papers authored by James B. Mangold

Since Specialization

Citations

This map shows the geographic impact of James B. Mangold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Mangold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Mangold more than expected).

Fields of papers citing papers by James B. Mangold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Mangold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Mangold. The network helps show where James B. Mangold may publish in the future.

Co-authorship network of co-authors of James B. Mangold

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Mangold. A scholar is included among the top collaborators of James B. Mangold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Mangold. James B. Mangold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Physiologically Based Pharmacokinetic Model Predictions of Panobinostat (LBH589) as a Victim and Perpetrator of Drug-Drug Interactions 2017 ·Drug Metabolism and Disposition ·Heidi J. Einolf, (unknown), (unknown), Lai Wang, Helen Gu, (unknown), Handan He, James B. Mangold	30
2	Compelling Relationship of CYP3A Induction to Levels of the Putative Biomarker 4β‐Hydroxycholesterol and Changes in Midazolam Exposure 2016 ·Clinical Pharmacology in Drug Development ·James B. Mangold, Fan Wu, Sam Rebello	7
3	Clinical disposition, metabolism andin vitrodrug–drug interaction properties of omadacycline 2016 ·Xenobiotica ·Jimmy Flarakos, (unknown), Helen Gu, Lai Wang, Heidi J. Einolf, (unknown), Bing Zhu, (unknown), (unknown), Imad Hanna, Lillian Ting, Wei Zhou, Kiran Dole, Haiying Sun, Steven J. Kovacs, Daniel S. Stein, Sébastien Tanaka, Stephen Villano, James B. Mangold	43
4	Physiologically based pharmacokinetic modeling for assessing the clinical drug–drug interaction of alisporivir 2014 ·European Journal of Pharmaceutical Sciences ·Binfeng Xia, Avantika Barve, Tycho Heimbach, Tao Zhang, Helen Gu, Lai Wang, Heidi J. Einolf, (unknown), Imad Hanna, (unknown), James B. Mangold, Handan He, Gangadhar Sunkara	11
5	An Industry Perspective on Tiered Approach to The Investigation of Metabolites in Drug Development 2014 ·Bioanalysis ·Su-Er W. Huskey, Wenkui Li, James B. Mangold, Jimmy Flarakos	3
6	Time‐Dependent Inhibition and Induction of Human Cytochrome P4503A4/5 by an Oral IAP Antagonist, LCL161, In Vitro and In Vivo in Healthy Subjects 2013 ·The Journal of Clinical Pharmacology ·Shyeilla V. Dhuria, Heidi J. Einolf, James B. Mangold, (unknown), Helen Gu, Lai Wang, Scott B. Cameron	17
7	Strategies and Chemical Design Approaches to Reduce the Potential for Formation of Reactive Metabolic Species 2011 ·Current Topics in Medicinal Chemistry ·Upendra A. Argikar, James B. Mangold, Shawn Harriman	15
8	Absorption, Metabolism, and Excretion of [14C]Vildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans 2008 ·Drug Metabolism and Disposition ·Handan He, (unknown), Hequn Yin, Harold T. Smith, Yannick Batard, Lai Wang, Heidi J. Einolf, Helen Gu, James B. Mangold, Volker Fischer, Dan Howard	119
9	Oxidative Metabolism of Epothilones A and B (Patupilone) by Cytochromes P450: Involvement of CYP3A and CYP2C 2008 ·HAL (Le Centre pour la Communication Scientifique Directe) ·(unknown), Alain Deroussent, Helen Gu, James B. Mangold, Hilmar Schiller, Gerhard Groß, Thierry Cresteil	1
10	Clinical Pharmacology of Lumiracoxib 2005 ·Clinical Pharmacokinetics ·Christiane Rordorf, (unknown), Paul Marshall, James B. Mangold	31
11	PHARMACOKINETICS AND METABOLISM OF LUMIRACOXIB IN HEALTHY MALE SUBJECTS 2004 ·Drug Metabolism and Disposition ·James B. Mangold, Helen Gu, Lolita C. Rodriguez, (unknown), (unknown), Christiane Rordorf	68
12	Effects of deuterium labeling on azido amino acid mutagenicity in Salmonella typhimurium 1994 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·James B. Mangold, (unknown), (unknown), (unknown)	4
13	Aryl sulfotransferase-IV-catalyzed sulfation of aryl oximes: steric and substituent effects 1993 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·James B. Mangold, Denis McCann, (unknown)	4
14	Self-catalyzed irreversible inactivation of rat hepatic aryl sulfotransferase IV by Nhydroxy-2-acetylaminofluorene 1990 ·Carcinogenesis ·Bonnie L.K. Mangold, (unknown), (unknown), Denis McCann, James B. Mangold	9
15	Selective protein arylation by acetaminophen and 2,6-dimethylacetaminophen in cultured hepatocytes from phenobarbital-induced and uninduced mice 1989 ·Biochemical Pharmacology ·Raymond B. Birge, John B. Bartolone, Denis McCann, James B. Mangold, Steven D. Cohen, Edward A. Khairallah	26
16	Sulfation of mono- and diaryl oximes by aryl sulfotransferase isozymes 1989 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·James B. Mangold, (unknown), Denis McCann	5
17	Azidoalanine mutagenicity in Salmonella: Effect of homologation and α-methyl substitution 1989 ·Mutation Research/Environmental Mutagenesis and Related Subjects ·James B. Mangold, (unknown), (unknown)	18
18	Dissociation of covalent binding from the oxidative effects of acetaminophen 1988 ·Biochemical Pharmacology ·Raymond B. Birge, John B. Bartolone, Ervant V. Nishanian, Mary K. Bruno, James B. Mangold, (unknown), Edward A. Khairallah	37
19	Synthesis and enantioselective mutagenicity of azidoalanine in Salmonella typhimurium 1986 ·Chemico-Biological Interactions ·James B. Mangold, (unknown)	12
20	Steroselectivity of the glutathione S-transferase catalyzed conjugation of aralkyl halides 1980 ·Biochemical and Biophysical Research Communications ·James B. Mangold, Mahmoud M. Abdel‐Monem	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact